Recruiting

Observational Study

Sponsor:

Beat COVID LLC

Code:

NCT04337762

Conditions

COVID-19

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

JUPITER is an observational study protocol that aims to understand factors that can help prevent/mitigate the spread of COVID-19 and understand factors that help reduce disease progression in patients with COVID-19. We aim to accomplish this by obtaining self-reported historical and longitudinal data from study participants.

Conditions

COVID-19

Study ID

NCT04337762

Start date

Apr 6, 2020

Status verified date

Apr, 2020

Completion date

Jul, 2021

Anticipated

Primary completion date

Dec, 2020

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Adults residing in the United States aged 18 years or older proficient in understanding and reading the English language who wish to participate in the fight against COVID-19 by providing self-reported health information.
2. Ability to complete electronic informed consent process.
3. Ability to use the internet and check email regularly.
4. Consent to provide a HIPAA waiver of health information to share protected health information.

Exclusion Criteria:

1. Inability to provide regular updates to their health status when contacted by the BEAT COVID study personnel via email or SMS.

Study Design

Enrollment

100000 participants

Anticipated

Interventions and Outcome Measures

Arms

Healthy

Healthy adult individuals residing in the United States with no history of COVID-19

COVID-19 Confirmed

United States adults that have tested positive for SARS-CoV-2 virus which causes the human disease COVID-19 (IE novel coronavirus) or those that have been exposed to a confirmed case and are awaiting testing

Primary outcome measure

  • Health Outcomes [ Time Frame: 1 year ]

Central Contacts and Locations

Central contacts

Locations

Beat COIVD, LLC

Recruiting

Chicago, Illinois, United States, 60452

More Information

Sponsor

Beat COVID LLC

Last update posted

Apr 9, 2020

Last verified

Apr, 2020

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Beat COVID LLC on 2020-04-09.